| Literature DB >> 30800077 |
Madhu Asnani-Kishnani1, Ana M Rodríguez1,2,3, Alba Serrano1,2, Andreu Palou1,2,3, M Luisa Bonet1,2,3, Joan Ribot1,2,3.
Abstract
Nutritional programming of the thermogenic and fuel oxidation capacity of white adipose tissue (WAT) through dietary interventions in early life is a potential strategy to enhance future metabolic health. We previously showed that mild neonatal supplementations with the polyphenol resveratrol (RSV) and the vitamin B3 form nicotinamide riboside (NR) have sex-dependent, long-term effects on the thermogenic/oxidative phenotype of WAT of mice in adulthood, enhancing this phenotype selectively in male animals. Here, we tested the hypothesis that these dietary interventions may impact the commitment of progenitor cells resident in the developing WAT toward brown-like (beige) adipogenesis. NMRI mice received orally from postnatal day 2-20 (P2-20) a mild dose of RSV or NR, in independent experiments; control littermates received the vehicle. Sex-separated primary cultures were established at P35 from the stromovascular fraction of inguinal WAT (iWAT) and of brown adipose tissue (BAT). Expression of genes related to thermogenesis and oxidative metabolism was assessed in the differentiated cultures, and in vivo in the iWAT depot of young (P35) animals. Neonatal RSV and NR treatments had little impact on the animals' growth during early postnatal life and the expression of thermogenesis- and oxidative metabolism-related genes in the iWAT depot of young mice. However, the expression of brown/beige adipocyte marker genes was upregulated in the iWAT primary cultures from RSV supplemented and NR supplemented male mice, and downregulated in those from supplemented female mice, as compared to cultures derived from sex-matched control littermates. RSV supplementation had similar sex-dependent effects on the expression of thermogenesis-related genes in the BAT primary cultures. A link between the sex-dependent short-term effects of neonatal RSV and NR supplementations on primary iWAT preadipocyte differentiation observed herein and their previously reported sex-dependent long-term effects on the thermogenic/oxidative capacity of adult iWAT is suggested. The results provide proof-of-concept that the fate of preadipocytes resident in WAT of young animals toward the beige adipogenesis transcriptional program can be modulated by specific food bioactives/micronutrients received in early postnatal life.Entities:
Keywords: adipose tissue; beigeing; browning; food bioactives; metabolic programming; primary culture; sex differences
Year: 2019 PMID: 30800077 PMCID: PMC6375887 DOI: 10.3389/fphys.2019.00083
Source DB: PubMed Journal: Front Physiol ISSN: 1664-042X Impact factor: 4.566
FIGURE 1Gene expression (mRNA levels) of the indicated genes in primary adipocyte cultures established from inguinal white adipose tissue (iWAT) of female (A) and male (B) mice neonatally supplemented throughout the suckling period with resveratrol (RSV) and their corresponding controls given the vehicle (water). Cells were harvested on day 7 of culture, under basal conditions and after 2 h incubation with noradrenaline (NA). Data are the mean ± SEM of 5–6 animals/group; mean value of controls under basal conditions used as reference and set to 100%. Statistics (p < 0.05): T, treatment; NA, noradrenaline (two-way ANOVA).
FIGURE 2Gene expression (mRNA levels) of the indicated genes in primary adipocyte cultures established from inguinal white adipose tissue (iWAT) of female (A) and male (B) mice neonatally supplemented throughout the suckling period with nicotinamide riboside (NR) and their corresponding controls given the vehicle (water). Cells were harvested on day 7 of culture, under basal conditions and after 2 h incubation with noradrenaline (NA). Data are the mean ± SEM of 5–6 animals/group; mean value of controls under basal conditions used as reference and set to 100%. Statistics (p < 0.05): T, treatment; NA, noradrenaline; TxNA, interactive effect (two-way ANOVA); ∗NR vs. control, #NA vs. basal (t-test).
FIGURE 3Gene expression (mRNA levels) of the indicated genes in primary adipocyte cultures established from brown adipose tissue (BAT) of female (A) and male (B) mice neonatally supplemented throughout the suckling period with resveratrol (RSV) and their corresponding controls given the vehicle (water). Cells were harvested on day 7 of culture, under basal conditions and after 2 h incubation with noradrenaline (NA). Data are the mean ± SEM of 5–6 animals/group; mean value of controls under basal conditions used as reference and set to 100%. Statistics (p < 0.05): T, treatment; NA, noradrenaline; TxNA, interactive effect (two-way ANOVA); ∗RSV vs. control, #NA vs. basal (t-test).
FIGURE 4Gene expression (mRNA levels) of the indicated genes in primary adipocyte cultures established from brown adipose tissue (BAT) of female (A) and male (B) mice neonatally supplemented throughout the suckling period with nicotinamide riboside (NR) and their corresponding controls given the vehicle (water). Cells were harvested on day 7 of culture, under basal conditions and after 2 h incubation with noradrenaline (NA). Data are the mean ± SEM of 5–6 animals/group; mean value of controls under basal conditions used as reference and set to 100%. Statistics (p < 0.05): T, treatment; NA, noradrenaline (two-way ANOVA).
Biometric parameters in mice receiving resveratrol (RSV) supplementation throughout lactation and their corresponding control littermates.
| Female | Male | |||
|---|---|---|---|---|
| Vehicle | RSV | Vehicle | RSV | |
| Day 3 | 2.7 ± 0.09 | 2.7 ± 0.17 | 2.7 ± 0.07 | 2.7 ± 0.07 |
| Day 12 | 7.5 ± 0.19 | 7.2 ± 0.18 | 7.5 ± 0.16 | 7.2 ± 0.16 |
| Day 21 | 13.8 ± 0.41 | 13.8 ± 0.41 | 14.9 ± 0.43 | 14.7 ± 0.38 |
| Day 30 | 23.7 ± 0.44 | 23.6 ± 0.65 | 27.9 ± 0.83 | 27.6 ± 0.67 |
| Cumulative energy intake from day 21 to day 30 (kcal/mice) | 115 ± 1.8 | 117 ± 0.3 | 143 ± 1.2 | 137 ± 2.2 |
| Body weight (g) | 26.6 ± 0.55 | 26.3 ± 0.47 | 31.4 ± 0.73 | 30.3 ± 0.53 |
| Fat mass (g) | 4.0 ± 0.31 | 4.0 ± 0.23 | 3.8 ± 0.26 | 3.4 ± 0.17 |
| Lean mass (g) | 20.0 ± 0.39 | 19.7 ± 0.35 | 25.2 ± 0.59 | 24.5 ± 0.40 |
| Fat mass (g/100 g bw) | 14.9 ± 0.97 | 15.3 ± 0.81 | 11.9 ± 0.60 | 11.2 ± 0.43 |
| Lean mass (g/100 g bw) | 75.1 ± 0.79 | 74.9 ± 0.76 | 80.6 ± 1.36 | 81.0 ± 0.36 |
| Ratio fat/lean mass | 0.168 ± 0.013 | 0.172 ± 0.010 | 0.128 ± 0.007 | 0.120 ± 0.005 |
| Naso-anal length (cm) | 9.2 ± 0.09 | 9.2 ± 0.07 | 9.5 ± 0.11 | 9.6 ± 0.13 |
| Lee index (g0.331000/cm) | 326 ± 03.1 | 323 ± 2.2 | 332 ± 2.2 | 324 ± 3.7 |
| Body weigth (g) | 26.2 ± 0.47 | 27.1 ± 0.65 | 31.4 ± 0.98 | 31.4 ± 0.63 |
| Inguinal WAT (g/100g bw) | 1.39 ± 0.10 | 1.58 ± 0.15 | 1.11 ± 0.07 | 1.15 ± 0.08 |
| Gonadal WAT (g/100g bw) | 1.14 ± 0.19 | 1.42 ± 0.23 | 1.23 ± 0.15 | 1.32 ± 0.10 |
| Interscapular BAT (g/100g bw) | 0.60 ± 0.04 | 0.72 ± 0.04 | 0.53 ± 0.04 | 0.60 ± 0.05 |
| Liver (g/100g bw) | 2.79 ± 1.11 | 2.09 ± 1.07 | 3.11 ± 1.26 | 3.30 ± 1.34 |
| Gastrocnemius SM (g/100 g bw) | 0.80 ± 0.04 | 0.90 ± 0.03 | 0.89 ± 0.04 | 0.88 ± 0.04 |
Biometric parameters in mice receiving nicotinamide riboside (NR) supplementation throughout lactation and their corresponding control littermates.
| Female | Male | |||
|---|---|---|---|---|
| Vehicle | NR | Vehicle | NR | |
| Day 3 | 2.9 ± 0.08 | 2.8 ± 0.07 | 3.1 ± 0.07 | 3.1 ± 0.06 |
| Day 12 | 7.1 ± 0.22 | 6.9 ± 0.21 | 7.0 ± 0.26 | 7.4 ± 0.21 |
| Day 21 | 12.4 ± 0.37 | 12.0 ± 0.32 | 12.5 ± 0.50 | 13.2 ± 0.39 |
| Day 30 | 19.7 ± 1.37 | 19.4 ± 1.21 | 21.3 ± 1.31 | 23.5 ± 1.62 |
| Cumulative energy intake from day 21 to day 30 (kcal/mice) | 128 ± 0.8 | 122 ± 1.6∗ | 159 ± 1.6 | 153 ± 1.6∗ |
| Body weigth (g) | 25.6 ± 0.38 | 26.1 ± 0.39 | 30.3 ± 0.48 | 32.0 ± 0.58∗ |
| Fat mass (g) | 2.9 ± 0.16 | 2.7 ± 0.16 | 2.4 ± 0.16 | 3.0 ± 0.22∗ |
| Lean mass (g) | 19.3 ± 0.34 | 19.7 ± 0.24 | 24.8 ± 0.39 | 25.8 ± 0.47 |
| Fat mass (g/100 g bw) | 11.4 ± 0.58 | 10.5 ± 0.49 | 7.8 ± 0.45 | 9.4 ± 0.60∗ |
| Lean mass (g/100 g bw) | 75.2 ± 0.55 | 75.3 ± 0.40 | 81.7 ± 0.49 | 80.7 ± 0.68 |
| Ratio fat/lean mass | 0.152 ± 0.009 | 0.139 ± 0.007 | 0.096 ± 0.006 | 0.118 ± 0.009∗ |
| Naso-anal length (cm) | 9.0 ± 0.10 | 8.9 ± 0.11 | 9.3 ± 0.07 | 9.3 ± 0.08 |
| Lee index (g0.331000/cm) | 328 ± 4.1 | 336 ± 4.4 | 336 ± 2.8 | 339 ± 3.2 |
| Body weigth (g) | 27.6 ± 0.82 | 27.4 ± 0.83 | 33.2 ± 0.60 | 35.0 ± 0.79 |
| Inguinal WAT (g/100g bw) | 1.41 ± 0.15 | 1.38 ± 0.15 | 1.08 ± 0.08 | 1.19 ± 0.04 |
| Gonadal WAT (g/100g bw) | 1.12 ± 0.24 | 0.93 ± 0.16 | 1.12 ± 0.14 | 1.47 ± 0.12 |
| Interscapular BAT (g/100g bw) | 0.60 ± 0.04 | 0.66 ± 0.07 | 0.63 ± 0.04 | 0.62 ± 0.03 |
| Liver (g/100g bw) | 2.18 ± 1.13 | 2.89 ± 1.17 | 3.44 ± 1.16 | 2.68 ± 1.44 |
| Gastrocnemius SM (g/100 g bw) | 0.88 ± 0.03 | 0.89 ± 0.01 | 0.94 ± 0.02 | 0.96 ± 0.03 |
FIGURE 5Gene expression (mRNA levels) of the indicated genes in inguinal white adipose tissue (iWAT) of 35-day-old male mice neonatally supplemented throughout the suckling period with resveratrol (RSV, A) or nicotinamide riboside (NR, B) relative to corresponding controls given the vehicle (water; dotted line). Data are the mean ± SEM of 5–6 animals/group. Statistics (p < 0.05): ∗RSV or NR vs. control (t-test).